Results 281 to 290 of about 125,568 (336)

Melanoma: Pathogenesis and Targeted Therapy

MedComm, Volume 7, Issue 1, January 2026.
The treatment landscape for advanced melanoma has evolved significantly. BRAF–MEK inhibitor combinations are standard for BRAF‐mutant melanoma, whereas targeting NRAS mutations is more challenging, with MEK inhibitors like tunlametinib emerging as an option.
Yang Fu, Jie Liu, Zeming Mo, Bin Wang, Yaotiao Deng, Yu Jiang   +5 more
wiley   +1 more source

Antimalarial potential of Matricaria chamomilla-derived MgO nanoparticles against Plasmodium falciparum strains: an experimental study. [PDF]

BMC Complement Med Ther
Farzaneh Z, Hanifian H, Nateghpour M, Hasanpour G, Raeisi A, Shabani M, Farivar L, Khezri A, Dehdast SA, Shahsavari S.   +9 more
europepmc   +1 more source

Radical Cure of Plasmodium vivax With Primaquine and CYP2D6 Polymorphism in Southeast Asia. [PDF]

Clin Infect Dis
Baird JK.
europepmc   +1 more source

Autophagy Modulates Immunogenic Cell Death in Cancer. [PDF]

Cancers (Basel)
Matsushita M, Moriwaki M.
europepmc   +1 more source

Epigenetic Regulation of Autophagy in Breast Cancer: Implications for Biomarker Discovery and Personalized Therapy. [PDF]

Cancer Rep (Hoboken)
Faryal B.
europepmc   +1 more source

Development of Nanotechnological Approaches to Improving the Antimalarial Potential of Natural Substances. [PDF]

Molecules
Yoncheva Y, Radeva L, Yoncheva K.
europepmc   +1 more source

The response of plasmodium falciparum to Chloroquine, Amodiaquine and Sulfadoxine/Pyrimethamine in Muhezi, North-Eastern Tanzania

, 2001
H.A. Msangeni
openalex   +1 more source